Initial studies on the administration route of prolactin

Area of Science:

• Pharmacokinetics
• Endocrinology
• Drug Delivery

Background:

• Prolactin is a vital hormone regulating numerous physiological processes.
• Understanding prolactin's bioavailability is crucial for therapeutic applications.
• Administration route significantly influences drug efficacy and availability.

Purpose of the Study:

• To determine the influence of different administration routes on prolactin's biological availability in rats.
• To compare prolactin concentrations in blood following intraperitoneal, intramuscular, and intranasal administration.

Main Methods:

• Single doses of 2.5 mg/kg body weight prolactin were administered to rats via intraperitoneal, intramuscular, and intranasal routes.
• Blood samples were collected over 5 hours post-administration.
• Prolactin concentrations were measured to determine bioavailability and pharmacokinetic parameters.

Main Results:

• Significant differences in blood prolactin concentrations were observed within 5 hours based on the administration route.
• Intraperitoneal administration yielded the highest maximal prolactin concentration, 1.5 times greater than intramuscular or intranasal routes.
• Area Under the Curve (AUC) values indicated comparable bioavailability for intraperitoneal (132.99 ng/cm3/h) and intramuscular (136.28 ng/cm3/h) routes, with intranasal administration showing a slightly lower AUC (111.30 ng/cm3/h).

Conclusions:

• The route of prolactin administration critically affects its biological availability in rats.
• Intraperitoneal administration appears most effective in achieving higher peak prolactin levels.
• Further research may optimize intranasal delivery for potential therapeutic benefits.